A top performer in the pharmaceuticals market, Sinopharm’s growth and popularity have taken the company to the forefront of research and development over the past decade. 2007 saw the firm announce revenue of over 25bn yuan. Aside from its developmental unit, the company also has a retail pharmacy chain stretching across Africa, France, Germany, Hong Kong, the US, and Vietnam. This year saw the company react to government healthcare reforms, sustaining growth in an industry in which many fell behind. As the nation’s foremost distributor, shares jumped almost twenty five percent with the government pledging its allegiance to this outstanding performer.